Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 1983-1991

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 324-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of malignancies and overall mortality in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 728-738

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

By Musso Giovanni   Gambino Roberto   Cassader Maurizio   Pagano Gianfranco  

Annals of Medicine, Vol. 43, Iss. 8, 2011-12 ,pp. : 617-649

Informa Healthcare

Access to resources Recommend Favorite

Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 170-177

Bentham Science Publishers

Access to resources Recommend Favorite